arrow
A

Anna Franzone

Federico II University of Naples
H指数:41
被引数:5,945

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study

替格瑞洛在行经皮冠状动脉介入治疗的ST段抬高型心肌梗死或非ST段抬高型心肌梗死患者中的药效学效应:POMPEII研究的启示

2026-04-150
OAAI
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg

老年ACS患者接受经皮冠状动脉介入治疗时,Ticagrelor 60 mg与90 mg的性别差异

2025-11-010
OA
CT assessment of right heart anatomy across tricuspid regurgitation severity grades: implications for transcatheter interventions

三尖瓣反流严重程度分级下右心解剖结构的CT评估:对经导管干预的启示

2025-09-010
OA
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial

经皮冠状动脉介入治疗后个体化或标准双重抗血小板治疗持续时间:PARTHENOPE随机试验

JACC
IF0
2025-08-300
PRE
Early Hemodynamic Performance of the SAPIEN 3 Ultra Resilia and Evolut Valves: A Propensity-Matched Analysis.

SAPIEN 3 Ultra Resilia和Evolut瓣膜的早期血流动力学性能:一项倾向性匹配分析。

2025-08-120
PRE
Incidence and predictors of persistent left atrial appendage patency and its subtypes after percutaneous closure: a pre-specified analysis of the SWISS-APERO trial

永久性左心耳通畅及其亚型的发生率和预测因素:SWISS-APERO试验的预先指定分析

2025-08-012
PRE
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR

瓣膜学术研究协会对接受TAVR的患者的高出血风险定义的验证

2025-01-010
PRE
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

在有和没有急性冠脉综合征的患者中,降阶梯至替格瑞洛单药治疗与双联抗血小板治疗12个月的比较: 一项系统评价和个体患者水平的随机试验荟萃分析

LANCET
IF88.5
2024-09-015
PRE
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after transcatheter aortic valve replacement: Insights from the Recovery-TAVR registry

经导管主动脉瓣置换术后患者发生假体-患者不匹配的超声心动图和临床特征: 来自Recovery-TAVR注册中心的见解

2024-09-011
PRE
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial
2024-07-181
PRE
Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation
2024-06-141
OAAI
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
2024-05-0123
PRE
CT Coronary Angiography: Technical Approach and Atherosclerotic Plaque Characterization
2023-12-113
OAAI